calendar
23,383 catalysts · 5,000 device 510k · 4,728 grant · 3,778 approval · 3,086 8k filing · 2,000 device pma · 2,000 device recall
23,383 catalysts · 5,000 device 510k · 4,728 grant · 3,778 approval · 3,086 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: GLENMARK PHARMS LTD. Form: CAPSULE. Route: ORAL
Sponsor: SANDOZ. Form: CAPSULE. Route: ORAL
Sponsor: SANDOZ. Form: CAPSULE. Route: ORAL
Sponsor: SANDOZ. Form: CAPSULE. Route: ORAL
Sponsor: SANDOZ. Form: CAPSULE. Route: ORAL
Sponsor: SANDOZ. Form: CAPSULE. Route: ORAL
Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: GILEAD SCIENCES INC. Form: TABLET. Route: ORAL
Sponsor: PHATHOM. Form: TABLET. Route: ORAL
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTION. Route: SOLUTION
Sponsor: QILU. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: CAPSULE. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: VALEANT LUXEMBOURG. Form: INJECTABLE. Route: INJECTION
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: GUERBET. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: BAYER HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: BAYER HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: ASTRAZENECA UK LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: ARGENX BV. Form: INJECTABLE. Route: INJECTION
Sponsor: SECURA. Form: CAPSULE. Route: ORAL
Sponsor: BRISTOL-MYERS. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
Sponsor: LUPIN. Form: CAPSULE. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: PHATHOM. Form: CAPSULE, TABLET, TABLET. Route: ORAL
Sponsor: PHATHOM. Form: CAPSULE, TABLET. Route: ORAL
Sponsor: AM REGENT. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL
Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL
Sponsor: IMPAX. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: ZYDUS LIFESCIENCES. Form: CAPSULE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: ARGENX BV. Form: INJECTABLE. Route: INJECTION
Sponsor: ARGENX BV. Form: INJECTABLE. Route: INJECTION
Sponsor: ARS PHARMS OPERATION. Form: SPRAY. Route: NASAL
Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION
Sponsor: SCPHARMACEUTICALS. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: ASCENDIS PHARMA BONE. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: STRIDES PHARMA INTL. Form: FOR SUSPENSION. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AMNEAL. Form: FOR SUSPENSION. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL